866-997-4948(US-Canada Toll Free)

Avedro, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 30 Pages


Avedro, Inc. (Averdro) is a medical device and pharmaceuticals company. The company has created cross linking device in the KXL system. The company also offers family of riboflavin products, that includes VibeX, VibeX Xtra, VibeX Rapid and ParaCel. Averdro has obtained CE Mark for its KXL system and its family of riboflavin products. However, its products are not for sale in the US. The company is headquartered in Waltham, Massachusetts, the US.

The company intents to expand its current patent portfolio as it entered into licensing agreement with EyeGate Pharmas iontophoresis patents in the field of corneal collagen cross-linking.

This report is a source for data, analysis and actionable intelligence on the Avedro, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
Avedro, Inc. - Major Products and Services 5
Avedro, Inc. Pipeline Products by Equipment Type 6
Avedro, Inc. Pipeline Products by Development Stage 8
Avedro, Inc. Pipeline Products by Therapy Area 10
Avedro, Inc. Pipeline Products by Trial Phase 12
Avedro, Inc. Pipeline Products by Milestone Summary 14
Keraflex Microwave System 16
Keraflex Microwave System Product Status 16
Keraflex Microwave System Product Description 16
Keraflex Microwave System Product Milestone 16
Keraflex Microwave System Clinical Trial 17
KXL II System 19
KXL II System Product Status 19
KXL II System Product Description 19
KXL System 20
KXL System Product Status 20
KXL System Product Description 20
KXL System Product Milestone 20
KXL System Clinical Trial 21
Vedera KXS System 23
Vedera KXS System Product Status 23
Vedera KXS System Product Description 23
Vedera KXS System Product Milestone 23
Avedro, Inc. - Key Employees 25
Avedro, Inc. - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Avedro, Inc., Recent Developments 27
May 02, 2012: Avedro To Present Seven Scientific Research Posters At ARVO Annual Meeting, Florida 27
Jan 31, 2012: Avedro Announces Canadian Approval For Lasik Xtra 27
Oct 13, 2011: Avedro Appoints A John Kanellopoulos To Its Medical Advisory Board 28
Sep 28, 2011: Avedro Appoints C Evan Ballantyne As CFO 28
May 17, 2011: Avedro Completes First US Phase III Corneal Cross-linking Clinical Trials 28

Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Table


Avedro, Inc., Key Facts 1
Avedro, Inc. Key Pipeline Products by Equipment Type 1
Avedro, Inc. Key Pipeline Products by Therapy Area 1
Avedro, Inc. Key Pipeline Products by Development Stage 1
Avedro, Inc. Key Pipeline Products by Trial Phase 1
Avedro, Inc., Key Facts 4
Avedro, Inc., Major Products and Services 5
Avedro, Inc. Number of Pipeline Products by Equipment Type 6
Avedro, Inc. Pipeline Products by Equipment Type 7
Avedro, Inc. Number of Pipeline Products by Development Stage 8
Avedro, Inc. Pipeline Products by Development Stage 9
Avedro, Inc. Number of Pipeline Products by Therapy Area 10
Avedro, Inc. Pipeline Products by Therapy Area 11
Avedro, Inc. Number of Pipeline Products by Trial Phase 12
Avedro, Inc. Pipeline Products by Trial Phase 13
Avedro, Inc. Number of Pipeline Products By Milestone Summary 14
Avedro, Inc. Pipeline Products by Milestone Summary 15
Keraflex Microwave System - Product Status 16
Keraflex Microwave System - Product Description 16
Keraflex Microwave System - Product Milestone 16
Keraflex Microwave System - A Randomized, Controlled Study of the Vedera KXS Microwave System With Corneal Collagen Cross-Linking Compared With Corneal Collagen Cross-Linking Alone for Eyes With Keratoconus 17
KXL II System - Product Status 19
KXL II System - Product Description 19
KXL System - Product Status 20
KXL System - Product Description 20
KXL System - Product Milestone 20
KXL System - A Phase 3, Multi-Center, Randomized, Controlled Evaluation To Study Accelerated Corneal Collagen Cross-Linking In Eyes With Keratoconus Or Corneal Ectasia After Refractive Surgery. 21
Vedera KXS System - Product Status 23
Vedera KXS System - Product Description 23
Vedera KXS System - Product Milestone 23
Avedro, Inc., Key Employees 25

List of Chart


Avedro, Inc. Key Pipeline Products by Equipment Type 1
Avedro, Inc. Pipeline Products by Equipment Type 6
Avedro, Inc. Pipeline Products by Development Stage 8
Avedro, Inc. Pipeline Products by Therapy Area 10
Avedro, Inc. Pipeline Products by Trial Phase 12
Avedro, Inc. Pipeline Products by Milestone Summary 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *